We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Abbott Laboratories’ promotional materials about the company’s HIV/AIDS drug Norvir are misleading and lacking complete risk information, the FDA’s Division of Drug Marketing, Advertising and Communication (DDMAC) said.